Skip to content
777 Sourcing.

Capability

genomic and clinical risk assessment

Suppliers
1
States & provinces
1
Countries
1

1 genomic and clinical risk assessment supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ICHORDX, INC

CHARLOTTE, NC

Rhythm Biosciences (ASX:RHY) is a medical diagnostics technology company transforming cancer diagnostics through innovative technologies that predict, detect, characterise, and support early intervention. Its flagship blood-based technology ColoSTAT® is a blood-based test for the detection of colorectal cancer in symptomatic patients, and the geneType™ platform is a personalised predictive test portfolio combining genomic and clinical information to predict risk of chronic disease development.

blood-based diagnosticscancer diagnosticsimmunoassay

Related capabilities

Other processes offered by the shops that list genomic and clinical risk assessment.

Browse all capabilities